NCT00526032View on ClinicalTrials.gov

Melanoma Detection by Oblique-Incidence Optical Spectroscopy

CompletedOBSERVATIONAL
Enrollment

490

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Skin Cancer
Interventions
PROCEDURE

OIR Imaging

Images from 4 different positions will be taken per lesion. The entire imaging procedure will take about 5 minutes per lesion.

Trial Locations (1)

77030

UT MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00526032 - Melanoma Detection by Oblique-Incidence Optical Spectroscopy | Biotech Hunter | Biotech Hunter